$SCYX
SCYNEXIS Inc

2021 Q1 Form 10-Q Financial Statement

#000156459021028188 Filed on May 17, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1
Revenue $12.05M $0.00
YoY Change -100.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $6.696M $2.613M
YoY Change 156.26% 16.6%
% of Gross Profit
Research & Development $6.948M $9.866M
YoY Change -29.58% 1.88%
% of Gross Profit
Depreciation & Amortization $27.00K $28.00K
YoY Change -3.57% -3.45%
% of Gross Profit
Operating Expenses $13.64M $12.48M
YoY Change 9.34% 4.65%
Operating Profit -$1.594M -$12.48M
YoY Change -87.23% 5.21%
Interest Expense $214.0K $210.0K
YoY Change 1.9% -42.78%
% of Operating Profit
Other Income/Expense, Net -$1.982M $5.477M
YoY Change -136.19% -149.58%
Pretax Income -$3.576M -$7.000M
YoY Change -48.91% -69.45%
Income Tax $1.100M
% Of Pretax Income
Net Earnings -$4.676M -$7.002M
YoY Change -33.22% -69.43%
Net Earnings / Revenue -38.8%
Basic Earnings Per Share -$0.18 -$0.72
Diluted Earnings Per Share -$0.23 -$0.72
COMMON SHARES
Basic Shares Outstanding 25.80M 9.745M
Diluted Shares Outstanding 26.52M 9.745M

Balance Sheet

Concept 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $92.00M $34.50M
YoY Change 166.67% -11.76%
Cash & Equivalents $92.00M $20.53M
Short-Term Investments $14.30M
Other Short-Term Assets $370.0K $914.0K
YoY Change -59.52% 1561.82%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $95.40M $36.80M
YoY Change 159.24% -8.23%
LONG-TERM ASSETS
Property, Plant & Equipment $3.200M $3.500M
YoY Change -8.57% -7.89%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.100M $1.200M
YoY Change -8.33% 0.0%
Total Long-Term Assets $4.700M $4.700M
YoY Change 0.0% -5.38%
TOTAL ASSETS
Total Short-Term Assets $95.40M $36.80M
Total Long-Term Assets $4.700M $4.700M
Total Assets $100.1M $41.50M
YoY Change 141.2% -7.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.500M $5.200M
YoY Change 25.0% 121.65%
Accrued Expenses $2.134M $1.800M
YoY Change 18.56% -18.59%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $24.90M $7.100M
YoY Change 250.7% 54.35%
LONG-TERM LIABILITIES
Long-Term Debt $12.20M $11.10M
YoY Change 9.91%
Other Long-Term Liabilities $37.00M $16.90M
YoY Change 118.93% 56.48%
Total Long-Term Liabilities $49.20M $28.00M
YoY Change 75.71%
TOTAL LIABILITIES
Total Short-Term Liabilities $24.90M $7.100M
Total Long-Term Liabilities $49.20M $28.00M
Total Liabilities $74.15M $35.05M
YoY Change 111.53% 3.9%
SHAREHOLDERS EQUITY
Retained Earnings -$331.3M -$278.4M
YoY Change 18.99% 15.71%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $25.92M $6.455M
YoY Change
Total Liabilities & Shareholders Equity $100.1M $41.51M
YoY Change 141.09% -7.89%

Cashflow Statement

Concept 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income -$4.676M -$7.002M
YoY Change -33.22% -69.43%
Depreciation, Depletion And Amortization $27.00K $28.00K
YoY Change -3.57% -3.45%
Cash From Operating Activities -$760.0K -$14.06M
YoY Change -94.59% 116.23%
INVESTING ACTIVITIES
Capital Expenditures -$200.0K $4.000K
YoY Change -5100.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$7.760M
YoY Change -100.0% -217.58%
Cash From Investing Activities -$200.0K -$7.762M
YoY Change -97.42% -217.66%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00 $214.0K
YoY Change -100.0% -91.73%
Debt Paid & Issued, Net $0.00
YoY Change -100.0%
Cash From Financing Activities -71.00K 152.0K
YoY Change -146.71% -89.26%
NET CHANGE
Cash From Operating Activities -760.0K -14.06M
Cash From Investing Activities -200.0K -7.762M
Cash From Financing Activities -71.00K 152.0K
Net Change In Cash -271.0K -21.67M
YoY Change -98.75% -1533.95%
FREE CASH FLOW
Cash From Operating Activities -$760.0K -$14.06M
Capital Expenditures -$200.0K $4.000K
Free Cash Flow -$560.0K -$14.06M
YoY Change -96.02% 116.29%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.1
CY2018Q1 us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2020Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.1
CY2020Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.1
CY2018Q1 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2020Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.1
CY2021Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y4M2D
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
0
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y8M15D
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P6Y8M19D
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P8Y3M29D
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
55000
CY2020Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
0
CY2021Q1 scyx Warrant Liabilities Current
WarrantLiabilitiesCurrent
16225000
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3215000
CY2021Q1 us-gaap Liabilities
Liabilities
74148000
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q1 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20625637
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20625637
CY2021Q1 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
21000
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
357192000
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-331289000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
25924000
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
100072000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12050000
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
13644000
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1594000
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-12479000
CY2021Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-2725000
CY2021Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
256000
CY2020Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
278000
CY2020Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2021Q1 us-gaap Interest Income Other
InterestIncomeOther
7000
CY2020Q1 us-gaap Interest Income Other
InterestIncomeOther
147000
CY2021Q1 us-gaap Interest Expense
InterestExpense
214000
CY2020Q1 us-gaap Interest Expense
InterestExpense
210000
CY2021Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0
CY2020Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
350000
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.18
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.72
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.23
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.72
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-4676000
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-7002000
CY2021Q1 us-gaap Depreciation
Depreciation
27000
CY2020Q1 us-gaap Depreciation
Depreciation
28000
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
398000
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
410000
CY2021Q1 us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
0
CY2020Q1 us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
31000
CY2021Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
256000
CY2020Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
278000
CY2021Q1 scyx Noncash Operating Lease Expense For Right Of Use Asset
NoncashOperatingLeaseExpenseForRightOfUseAsset
49000
CY2020Q1 scyx Noncash Operating Lease Expense For Right Of Use Asset
NoncashOperatingLeaseExpenseForRightOfUseAsset
48000
CY2021Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-2725000
CY2020Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2021Q1 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-1736000
CY2020Q1 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-1734000
CY2021Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-68000
CY2020Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-4054000
CY2021Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
200000
CY2020Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0
CY2021Q1 us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
0
CY2020Q1 us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
14235000
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-200000
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7762000
CY2021Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0
CY2020Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
214000
CY2021Q1 scyx Payments Of Offering Costs And Underwriting Discounts And Commissions
PaymentsOfOfferingCostsAndUnderwritingDiscountsAndCommissions
62000
CY2020Q1 scyx Payments Of Offering Costs And Underwriting Discounts And Commissions
PaymentsOfOfferingCostsAndUnderwritingDiscountsAndCommissions
7000
CY2021Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
6000
CY2020Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
18000
CY2021Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
15000
CY2020Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
73000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-71000
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
152000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-1030000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-21667000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
93314000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
42193000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
92284000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20526000
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
420000
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
420000
CY2021Q1 us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
5000
CY2020Q1 us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
129000
CY2021Q1 us-gaap Stock Issued1
StockIssued1
7452000
CY2020Q1 us-gaap Stock Issued1
StockIssued1
0
CY2021Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
178000
CY2020Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
0
CY2021Q1 scyx Deferred Offering Costs Incurred But Not Yet Paid
DeferredOfferingCostsIncurredButNotYetPaid
0
CY2020Q1 scyx Deferred Offering Costs Incurred But Not Yet Paid
DeferredOfferingCostsIncurredButNotYetPaid
40000
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-331300000
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
92000000.0
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-4676000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-7002000
CY2021Q1 scyx Dilutive Securities Effect On Basic Earnings Per Share Warrant Liability
DilutiveSecuritiesEffectOnBasicEarningsPerShareWarrantLiability
-1323000
CY2020Q1 scyx Dilutive Securities Effect On Basic Earnings Per Share Warrant Liability
DilutiveSecuritiesEffectOnBasicEarningsPerShareWarrantLiability
0
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-5999000
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-7002000
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25802700
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9744577
CY2021Q1 scyx Incremental Common Shares Attributable To Warrant Liabilities
IncrementalCommonSharesAttributableToWarrantLiabilities
721220
CY2020Q1 scyx Incremental Common Shares Attributable To Warrant Liabilities
IncrementalCommonSharesAttributableToWarrantLiabilities
0
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26523920
CY2020Q4 us-gaap Prepaid Insurance
PrepaidInsurance
362000
CY2021Q1 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
525000
CY2020Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
19000
CY2021Q1 us-gaap Other Receivables
OtherReceivables
1000000
CY2020Q4 us-gaap Other Receivables
OtherReceivables
2876000
CY2021Q1 us-gaap Other Assets Current
OtherAssetsCurrent
370000
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
373000
CY2021Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3310000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5165000
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9744577
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.23
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.72
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
15111905
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7697433
CY2021Q1 scyx Prepaid Researchand Development Expenses Current
PrepaidResearchandDevelopmentExpensesCurrent
1300000
CY2020Q4 scyx Prepaid Researchand Development Expenses Current
PrepaidResearchandDevelopmentExpensesCurrent
1535000
CY2021Q1 us-gaap Prepaid Insurance
PrepaidInsurance
115000
CY2021Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1054000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
960000
CY2021Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2134000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4141000
CY2018Q1 scyx Lease Agreement Area Of Office Space
LeaseAgreementAreaOfOfficeSpace
19275
CY2018Q1 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P11Y
CY2018Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
7300000
CY2021Q1 us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
The Company has the option to renew for two consecutive five-year periods from the end of the first term and the Company is not reasonably certain that the option to renew the Lease will be exercised. Under the Lease, the Company furnished a security deposit in the form of a standby letter of credit in the amount of $0.3 million, which was reduced by fifty-five thousand dollars on the first anniversary of the commencement date.  The security deposit will continue to be reduced by fifty-five thousand dollars every two years on the commencement date anniversary for eight years.
CY2018Q1 us-gaap Security Deposit
SecurityDeposit
300000
CY2018Q1 us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
55000
CY2021Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
166000
CY2020Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
166000
CY2021Q1 scyx Variable Lease Cost And Income
VariableLeaseCostAndIncome
-2000
CY2020Q1 scyx Variable Lease Cost And Income
VariableLeaseCostAndIncome
21000
CY2021Q1 us-gaap Lease Cost
LeaseCost
164000
CY2020Q1 us-gaap Lease Cost
LeaseCost
187000
CY2021Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
170000
CY2020Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
167000
CY2020Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.15
CY2020Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-73000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
6455000
CY2021Q1 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
27510704
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
347000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
527000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
715000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
730000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
744000
CY2021Q1 scyx Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
2789000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
5852000
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
3272000
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
57000
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3215000
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
3272000
CY2021Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2580000
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20625637
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20625637
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19663698
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19663698
CY2021Q1 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-10
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
22758000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-4676000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
398000
CY2021Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
6000
CY2021Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-15000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
25924000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
12895000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-7002000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
410000
CY2020Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
18000
CY2020Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
207000
CY2020Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
28028978
CY2021Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1300000
CY2020Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-4800000
CY2021Q1 scyx Fair Value Of Liabilities
FairValueOfLiabilities
49900000
CY2020Q1 scyx Fair Value Of Liabilities
FairValueOfLiabilities
51200000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
830343
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
21.52
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
96000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
545450
CY2021Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
7.57
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
4187
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
8.48
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1371606
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
16.01
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
355000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
500625
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
29.27
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
37000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1371606
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
16.01
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
355000
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
400000
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
400000
CY2021Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0
CY2020Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
398000
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
410000

Files In Submission

Name View Source Status
0001564590-21-028188-index-headers.html Edgar Link pending
0001564590-21-028188-index.html Edgar Link pending
0001564590-21-028188.txt Edgar Link pending
0001564590-21-028188-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
scyx-10q_20210331.htm Edgar Link pending
scyx-10q_20210331_htm.xml Edgar Link completed
scyx-20210331.xsd Edgar Link pending
scyx-20210331_cal.xml Edgar Link unprocessable
scyx-20210331_def.xml Edgar Link unprocessable
scyx-20210331_lab.xml Edgar Link unprocessable
scyx-20210331_pre.xml Edgar Link unprocessable
scyx-ex101_86.htm Edgar Link pending
scyx-ex102_87.htm Edgar Link pending
scyx-ex311_12.htm Edgar Link pending
scyx-ex312_11.htm Edgar Link pending
scyx-ex321_8.htm Edgar Link pending
Show.js Edgar Link pending